Literature DB >> 12508278

Activation of the JNK signaling pathway: breaking the brake on apoptosis.

Anning Lin1.   

Abstract

The JNK signaling pathway is involved in regulation of many cellular events, including growth control, transformation and programmed cell death (apoptosis). The role of JNK activation in apoptosis is highly controversial, being suggested to have a pro-apoptotic, anti-apoptotic or no role in this process. It appears that the JNK pathway functions in a cell-type and stimulus-dependent manner and its different components can sometimes play opposing roles in apoptosis. Recent studies reveal that the effect of JNK activation on apoptosis depends on the activity of other signaling pathways like the NF-kappaB pathway. Here we propose a model that can explain how activation of the JNK pathway "breaks the brake" on apoptosis, thereby regulating, but not initiating the apoptotic process. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12508278     DOI: 10.1002/bies.10204

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  109 in total

1.  Foxo and Fos regulate the decision between cell death and survival in response to UV irradiation.

Authors:  Xi Luo; Oscar Puig; Joogyung Hyun; Dirk Bohmann; Heinrich Jasper
Journal:  EMBO J       Date:  2006-12-21       Impact factor: 11.598

2.  The protective role of 5-hydroxymethyl-2-furfural (5-HMF) against acute hypobaric hypoxia.

Authors:  Ming-Ming Li; Li-Ying Wu; Tong Zhao; Kui-Wu Wu; Lei Xiong; Ling-Ling Zhu; Ming Fan
Journal:  Cell Stress Chaperones       Date:  2011-04-15       Impact factor: 3.667

3.  Requirements for PKC-augmented JNK activation by MKK4/7.

Authors:  Pablo Lopez-Bergami; Ze'ev Ronai
Journal:  Int J Biochem Cell Biol       Date:  2007-12-03       Impact factor: 5.085

4.  Inhibiting JNK dephosphorylation and induction of apoptosis by novel anticancer agent NSC-741909 in cancer cells.

Authors:  Xiaoli Wei; Wei Guo; Shuhong Wu; Li Wang; Yiling Lu; Bo Xu; Jinsong Liu; Bingliang Fang
Journal:  J Biol Chem       Date:  2009-05-04       Impact factor: 5.157

5.  Transcription of the protein kinase C-delta gene is activated by JNK through c-Jun and ATF2 in response to the anticancer agent doxorubicin.

Authors:  Byong Wook Min; Chang Gun Kim; Jesang Ko; Yoongho Lim; Young Han Lee; Soon Young Shin
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

6.  TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.

Authors:  You-Sun Kim; Sergei A Nedospasov; Zheng-Gang Liu
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.

Authors:  Jing Liu; Yuzuru Minemoto; Anning Lin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

8.  Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells.

Authors:  Maria E Gonzalez; Olga Makarova; Esther A Peterson; Lisa M Privette; Elizabeth M Petty
Journal:  Cell Signal       Date:  2008-11-18       Impact factor: 4.315

Review 9.  Targeting ricin to the ribosome.

Authors:  Kerrie L May; Qing Yan; Nilgun E Tumer
Journal:  Toxicon       Date:  2013-02-20       Impact factor: 3.033

10.  E4orf4 induces PP2A- and Src-dependent cell death in Drosophila melanogaster and at the same time inhibits classic apoptosis pathways.

Authors:  Antonina Pechkovsky; Maoz Lahav; Eliya Bitman; Adi Salzberg; Tamar Kleinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.